LS
Lakshman Samala
About Lakshman Samala
Data last updated:
Lakshman Samala is a Director at Novelix Pharmaceuticals Limited (since 2025). The company operates in Pharma. Novelix Pharmaceuticals Limited reported revenue of ₹4.53 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novelix Pharmaceuticals Limited L67120TG1994PLC018956 | Director | 12 Feb 2025 | 1994 | ₹4.53 Cr (FY 2024) | Active |
Board colleagues of Lakshman Samala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhoomika Choudhary | Novelix Pharmaceuticals Limited | Cfo | |
| Gnana Prakash Gattu | 00517921 | Novelix Pharmaceuticals Limited | Director |
| Janardhan Das Kabra | 02386627 | Novelix Pharmaceuticals Limited | Director |
| Mayuri Baidya | 11242323 | Novelix Pharmaceuticals Limited | Director |
| Nishita Kalantri | Novelix Pharmaceuticals Limited | Company Secretary | |
| Sridevi Belide | 10455373 | Novelix Pharmaceuticals Limited | Additional Director |
| Venkateshwarlu Pulluru | 02076871 | Novelix Pharmaceuticals Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lakshman Samala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lakshman Samala
Lakshman Samala currently holds 1 directorship: Novelix Pharmaceuticals Limited (Director, since 12 Feb 2025, revenue ₹4.53 Cr (FY 2024)).
Lakshman Samala was first appointed on 12 Feb 2025 as Director at Novelix Pharmaceuticals Limited.
The current boards of Lakshman Samala's companies include Bhoomika Choudhary (Novelix Pharmaceuticals Limited), Gnana Prakash Gattu (Novelix Pharmaceuticals Limited), Janardhan Das Kabra (Novelix Pharmaceuticals Limited), Mayuri Baidya (Novelix Pharmaceuticals Limited), Nishita Kalantri (Novelix Pharmaceuticals Limited), Sridevi Belide (Novelix Pharmaceuticals Limited), among others.